CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to identify mutations in noncoding regions of the genome that contribute to cancer development. By analyzing a large number of tumors, it seeks to uncover new therapeutic targets and enhance understanding of cancer biology.
Finding the mutations, genes and pathways directly involved in cancer is of paramount importance to understand the mechanisms of tumour development and devise therapeutic strategies to overcome the disease.
Due to their role in cancer development and maintenance, the proteins encoded by cancer genes are candidate therapeutic targets.
Indeed, in recent years we have witnessed the development of successful cancer-targeting therapies to counteract the effect of driver mutations.
Although the coding…
FUNDACIO INSTITUT DE RECERCA BIOMEDICA (IRB BARCELONA)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
